I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!
I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!
And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic
Savvy Updates, 10/31/22: Dexcom Profit Surges, New Islet Cell Transplant Method, Almonds and Gut Microbiome, Breath Vapors Algorithm into BG Readings
Dexcom Q3 profit surges as CGM maker prepares for G7 launch in U.S. was reported by Elise Reuter for MedTechDive.com, 28 October 2022. The company expects to begin selling its newest continuous glucose monitor in the first quarter of 2023 if it receives FDA...
Savvy Updates, 10/24/22: Omnipod DASH PDM Recall, Insulin Rationing in the US (SHAMEFUL!), Wearable Tech to Charge Devices
Insulet flags battery problem with Omnipod DASH system was posted by Elise Reuter for MedTechDive.com, 17 October 2022. Insulet issued an urgent medical device correction, on 17 October 2022, related to battery problems with a component of its Omnipod...
Savvy Updates, 10/17/22: Dexcom G7 Global Rollout, T2D Drugs Help T1Ds, BefA Gut Bacteria & Beta Cell Production, FDA TAP Pilot Program for New D Devices
Dexcom Announces Global Rollout of G7, as reported by Andrew Briskin for diaTribe.org, 10 October 2022. Dexcom, one of the leading manufacturers of CGM, announced on Oct. 4 that its latest product, the Dexcom G7, is now available for people with diabetes, ages 2...
Savvy Updates, 10/10/22: Indigo Continuous Multi-Metabolite (CMM) Sensor, T1D More Difficult/Dangerous for Girls
Indigo Diabetes enrolls first subject in multi-metabolite sensor trial was published by MedicalDevice-Network.com, 30 September 2022. Belgian diabetes device company Indigo Diabetes has enrolled the first participant in the Shine (multi-center, open-label,...
Savvy Apps 10/6/22: Gluroo with Greg Badros, CEO/Developer
Join Loop and Learn for a FREE Zoom Event about a cool app for T1Ds. GLUROO with Greg Badros The Diabetes Logging app that makes managing diabetes as easy as messaging Sunday, 9 October 2022, 5pm PT/8pm ET Zoom: https://us02web.zoom.us/j/84171589505 YouTube...
Savvy Updates, 10/3/22: EASD 2022 Highlights, Diabetes Product Waste, All About Fat, Bolusing for Fats & Proteins
Highlights From EASD 2022 was written by Andrew Briskin, Arvind Sommi and Natalie Sainz for diaTribe.org, 21 September 2022. Here's a great overview of presentations at this year's EASD (European Association for the Study of Diabetes) Annual Meeting, held in...
Interview by Kamil Armacki (aka, Nerdabetic) with Dexcom’s Jake Leach, 23 September 2022
Kamil Armacki shared on his YouTube channel: As many of you know Dexcom G7 was CE marked earlier this year. During this year's annual EASD conference in Stockholm, Sweden (September 2022), I sat down with Dexcom's Jake Leach - Chief Operating Officer to get the...
Savvy Updates, 9/26/22: Medtronic Pumps & Cybersecurity Risk, Diabeloop Algorithm Increases TIR, T1D & UTIs, Moderate Diabetes Distress Even with CGM
FDA Warns of Cybersecurity Risk With Medtronic MiniMed 600 Series Insulin Pumps was reported by David Kerr, MD, for Healio.com/endocrinology, 20 September 2022. The FDA has issued an alert warning people with diabetes using a Medtronic MiniMed 630G or MiniMed 670G...
Savvy Updates, 9/19/22: Investor Lawsuit against Medtronic, Synthetic Human Gut Microbiome, Sex of Researcher Affects Study Outcomes, Loss of “Caring” in Healthcare
Investor lawsuit accuses Medtronic of failing to disclose insulin pump problems was posted by Mick Paul Taylor for MedTechDive.com, 13 September 2022. Investors have accused Medtronic of failing to disclose problems with its insulin pump business that...
Savvy Updates 9/12/22: Novo saves Zegalogue, Sugar Disrupts Microbiome, Cravings for Fatty Foods, DPAC Sues HHS for Copay Accumulators, Best Places for Dexcom G6 Sensor
Zealand summons Novo Nordisk to resuscitate floundering diabetes newcomer Zegalogue was reported by Fraiser Kansteiner for FiercePharma.com, 7 September 2022. Zealand said it has forged a global license and development pact with Novo Nordisk to take the marketing...
More Diabetes Blogs